Maximum quantity allowed is 999
Please select the quantity
CAS RN: 33797-51-2 | Product Number: D1646
N,N-Dimethylmethyleneammonium Iodide
Purity: >97.0%(T)
Synonyms:
- Eschenmoser's Salt
- N,N-Dimethylmethyleneiminium Iodide
Product Documents:
* Available Stock: Prompt shipment (for products) in Saitama/Hyogo warehouse. Stock In Other WH: Shipment in about 2-3 Business Days from Saitama warehouse. Please contact us
if you need further information.
* The displayed price is the unit price and does not include consumption tax. The unit prices displayed are the latest and are subject to change without notice.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* The displayed price is the unit price and does not include consumption tax. The unit prices displayed are the latest and are subject to change without notice.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | D1646 |
Purity / Analysis Method | >97.0%(T) |
Molecular Formula / Molecular Weight | C__3H__8IN = 185.01 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Light Sensitive,Moisture Sensitive,Heat Sensitive |
CAS RN | 33797-51-2 |
Reaxys Registry Number | 3594966 |
PubChem Substance ID | 87568123 |
SDBS (AIST Spectral DB) | 19772 |
Merck Index (14) | 3251 |
MDL Number | MFCD00011810 |
Specifications
Appearance | White to Gray to Brown powder to crystal |
Purity(Nonaqueous Titration) | min. 97.0 % |
Properties (reference)
GHS
Pictogram | |
Signal Word | Warning |
Hazard Statements | H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
Precautionary Statements | P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. |
Related Laws:
Transport Information:
Application
Bromination
Typical Procedure:
To a cold (-20 °C) solution of diisopropylamine (50 mg, 0.492 mmol) in THF (630 µL) is added the solution of n-butyllithium in hexane (294 µL of the 1.67 M solution, 0.491 mmol). The solution is stirred for 15 min at that temperature, then cooled to -78 ℃ and the solution of 1 (91.3 mg, 0.447 mmol) in THF (400 µL) is added. HMPA (319 mg, 1.78 mmol) is added to the solution of the lithium enolate, and the resulting solution is transferred via cannula to a cold (-78 °C) suspension of the Eschenmoser's salt (200 mg, 1.08 mmol) in THF (1 mL). The reaction mixture is allowed to reach rt with stirring, when the yellow suspension turned into solution. The reaction is quenched with saturated aqueous NaHCO3 (10 mL) and the product is extracted with ethyl acetate (4 x 25 mL). The organic extract is washed with brine, dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. The crude residue (430 mg) is dissolved in diethyl ether (3 mL), methyl iodide (1 mL, 16.28 mmol) is added and the reaction mixture is stirred at rt for 2 hours. The solution of NaOAc (1.2 g) in water (7 mL) is added and the reaction mixture is vigorously stirred for 1 hour. The mixture is diluted with hexane (80 mL) and water (10 mL), the phases are separated and the aqueous phase is extracted with hexane (2 x 10 mL). The combined extract is thoroughly washed with water, dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. Purification of the crude organic residue (107 mg) by column chromatography (gradient elution with hexane : diethyl ether = 95 : 5 → 9 : 1) affords 2 (28 mg, Y. 53%).
To a cold (-20 °C) solution of diisopropylamine (50 mg, 0.492 mmol) in THF (630 µL) is added the solution of n-butyllithium in hexane (294 µL of the 1.67 M solution, 0.491 mmol). The solution is stirred for 15 min at that temperature, then cooled to -78 ℃ and the solution of 1 (91.3 mg, 0.447 mmol) in THF (400 µL) is added. HMPA (319 mg, 1.78 mmol) is added to the solution of the lithium enolate, and the resulting solution is transferred via cannula to a cold (-78 °C) suspension of the Eschenmoser's salt (200 mg, 1.08 mmol) in THF (1 mL). The reaction mixture is allowed to reach rt with stirring, when the yellow suspension turned into solution. The reaction is quenched with saturated aqueous NaHCO3 (10 mL) and the product is extracted with ethyl acetate (4 x 25 mL). The organic extract is washed with brine, dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. The crude residue (430 mg) is dissolved in diethyl ether (3 mL), methyl iodide (1 mL, 16.28 mmol) is added and the reaction mixture is stirred at rt for 2 hours. The solution of NaOAc (1.2 g) in water (7 mL) is added and the reaction mixture is vigorously stirred for 1 hour. The mixture is diluted with hexane (80 mL) and water (10 mL), the phases are separated and the aqueous phase is extracted with hexane (2 x 10 mL). The combined extract is thoroughly washed with water, dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. Purification of the crude organic residue (107 mg) by column chromatography (gradient elution with hexane : diethyl ether = 95 : 5 → 9 : 1) affords 2 (28 mg, Y. 53%).
References
- Ring-Closing Metathesis/Fragmentation Route to Geometrically Defined Medium-Ring Cycloalkenes: Total Synthesis of (±)-Periplanone C.
PubMed Literature
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.